To assess the value of type I11 procollagen peptide (sPIIIP) as a marker of hepatic fibrosis, sera from 73 patients with alcohol-related liver disease and 30 patients with idiopathic hemochromatosis (IHC) were studied by a specific radioimmunoassay. sPIIIP was increased in 87% of 30 patients with ci
Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: Relation to disease activity and effect of chemotherapy
✍ Scribed by Dr. H. Hasselbalch; P. Junker; K. Hørslev-Petersen; I. Lisse; K. D. Bentsen
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 748 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To analyze the correlations between the presence of cirrhosis and hepatocellular inflammation and the serum concentrations of the amino-terminal peptide of procollagen type 111 in chronic liver disease, we measured prodlagen type 1 1 1 concentrations in paired serum samples from 46 patients (17 had
To assess the clinical value of serum biochemical markers, the aminoterminal peptide of type III procollagen, type IV collagen 7S domain, the central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases, as a marker of hepatic fibrosis, we measured these four serum markers in